{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:27:16Z","timestamp":1785241636702,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["201607010119"],"award-info":[{"award-number":["201607010119"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010124"],"award-info":[{"award-number":["2020A1515010124"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271196"],"award-info":[{"award-number":["81271196"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We previously reported a correlation between small doses of oxaliplatin penetrating onto the spinal cord and acute pain after chemotherapy. Here, we propose that MT2 within the spinal dorsal horns participates in the development of oxaliplatin-induced neuropathic pain and may be a pharmacological target for the prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The rat model of CIPN was established by 5 consecutive injections of oxaliplatin (0.4 mg\/100 g\/day). Genetic restoration of neuron-specific metallothionein-2 was implemented 21 days before oxaliplatin treatment, and also, genetic inhibition by metallothionein-2 siRNA was performed. Mechanical allodynia and locomotor activity were assayed. Cell-specific expression of metallothionein-2, the mRNA levels of pro-inflammatory cytokines, nuclear translocation of NF-\u03baB, the protein levels of expression of I\u03baB-\u03b1, and interaction between I\u03baB-\u03b1 and P65 were evaluated in the spinal dorsal horns. Also, in vitro interaction of sequentially deleted I\u03baB-\u03b1 promoter with metallothionein-2 was used to assess the signal transduction mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that oxaliplatin induced downregulation of metallothionein-2 in rat spinal cord neurons. By contrast, genetic restoration of metallothionein-2 in the spinal dorsal horn neuron blocked and reversed neuropathic pain in oxaliplatin-treated rats of both sexes, whereas genetic inhibition of metallothionein-2 triggered neuropathic pain in normal rats. Overall locomotor activity was not impaired after the genetic alterations of metallothionein-2. At the molecular level, metallothionein-2 modulated oxaliplatin-induced neuroinflammation, activation of NF-\u03baB, and inactive transcriptional expression of I\u03baB-\u03b1 promoter, and these processes could be blocked by genetic restoration of metallothionein-2 in the spinal dorsal horn neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Metallothionein-2 is a potential target for the prevention and treatment of CIPN. A reduction of NF-\u03baB activation and inflammatory responses by enhancing the transcription of I\u03baB-\u03b1 promoter is proposed in the mechanism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-021-02139-6","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T09:14:14Z","timestamp":1618305254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Downregulation of metallothionein-2 contributes to oxaliplatin-induced neuropathic pain"],"prefix":"10.1186","volume":"18","author":[{"given":"Xuelin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-7994","authenticated-orcid":false,"given":"Xiangcai","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"issue":"12","key":"2139_CR1","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208\u201315. https:\/\/doi.org\/10.1016\/S1470-2045(13)70447-9.","journal-title":"Lancet Oncol"},{"issue":"18","key":"2139_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941\u201367. https:\/\/doi.org\/10.1200\/JCO.2013.54.0914.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2139_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00520-014-2242-z","volume":"22","author":"AJ Beijers","year":"2014","unstructured":"Beijers AJ, Mols F, Vreugdenhil G. A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration. Support Care Cancer. 2014;22(7):1999\u20132007. https:\/\/doi.org\/10.1007\/s00520-014-2242-z.","journal-title":"Support Care Cancer"},{"issue":"8","key":"2139_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/02841860701355055","volume":"46","author":"AA Argyriou","year":"2007","unstructured":"Argyriou AA, Polychronopoulos P, Iconomou G, Koutras A, Makatsoris T, Gerolymos MK, et al. Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. Acta Oncol. 2007;46(8):1131\u20137. https:\/\/doi.org\/10.1080\/02841860701355055.","journal-title":"Acta Oncol"},{"issue":"1","key":"2139_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12885-019-5302-4","volume":"19","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis A, Cheng HL, Lopez V, Au JSK, Chan A, Bandla A, et al. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer. 2019;19(1):132. https:\/\/doi.org\/10.1186\/s12885-019-5302-4.","journal-title":"BMC Cancer"},{"issue":"7","key":"2139_CR6","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.clinph.2017.04.009","volume":"128","author":"T Kandula","year":"2017","unstructured":"Kandula T, Farrar MA, Kiernan MC, Krishnan AV, Goldstein D, Horvath L, et al. Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer. Clin Neurophysiol. 2017;128(7):1166\u201375. https:\/\/doi.org\/10.1016\/j.clinph.2017.04.009.","journal-title":"Clin Neurophysiol"},{"issue":"28","key":"2139_CR7","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1200\/JCO.2011.36.4539","volume":"29","author":"G Yothers","year":"2011","unstructured":"Yothers G, O\u2019Connell MJ, Allegra CJ, Kuebler JP, Colangelo LH, Petrelli NJ, et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol. 2011;29(28):3768\u201374. https:\/\/doi.org\/10.1200\/JCO.2011.36.4539.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2139_CR8","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s00520-013-1905-5","volume":"21","author":"C Tofthagen","year":"2013","unstructured":"Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy\u2019s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. 2013;21(12):3307\u201313. https:\/\/doi.org\/10.1007\/s00520-013-1905-5.","journal-title":"Support Care Cancer"},{"issue":"21","key":"2139_CR9","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","volume":"31","author":"F Mols","year":"2013","unstructured":"Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol. 2013;31(21):2699\u2013707. https:\/\/doi.org\/10.1200\/JCO.2013.49.1514.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2139_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SPC.0b013e328342f9cc","volume":"5","author":"P Farquhar-Smith","year":"2011","unstructured":"Farquhar-Smith P. Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care. 2011;5(1):1\u20137. https:\/\/doi.org\/10.1097\/SPC.0b013e328342f9cc.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"10","key":"2139_CR11","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS, Jahn P, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306\u201319. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.003.","journal-title":"Ann Oncol"},{"issue":"9","key":"2139_CR12","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1002\/ijc.33106","volume":"147","author":"J Deng","year":"2020","unstructured":"Deng J, Ding HH, Long JL, Lin SY, Liu M, Zhang XQ, et al. Oxaliplatin-induced neuropathic pain involves HOXA6 via a TET1-dependent demethylation of the SOX10 promoter. Int J Cancer. 2020;147(9):2503\u201314. https:\/\/doi.org\/10.1002\/ijc.33106.","journal-title":"Int J Cancer"},{"issue":"39","key":"2139_CR13","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1523\/JNEUROSCI.1956-15.2015","volume":"35","author":"Y Li","year":"2015","unstructured":"Li Y, Adamek P, Zhang H, Tatsui CE, Rhines LD, Mrozkova P, et al. The cancer chemotherapeutic paclitaxel increases human and rodent sensory neuron responses to TRPV1 by activation of TLR4. J Neurosci. 2015;35(39):13487\u2013500. https:\/\/doi.org\/10.1523\/JNEUROSCI.1956-15.2015.","journal-title":"J Neurosci"},{"key":"2139_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuroscience.2011.10.010","volume":"199","author":"WH Xiao","year":"2011","unstructured":"Xiao WH, Zheng H, Zheng FY, Nuydens R, Meert TF, Bennett GJ. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat. Neuroscience. 2011;199:461\u20139. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.10.010.","journal-title":"Neuroscience"},{"issue":"5","key":"2139_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/ALN.0000000000001084","volume":"124","author":"ZZ Huang","year":"2016","unstructured":"Huang ZZ, Li D, Ou-Yang HD, Liu CC, Liu XG, Ma C, et al. Cerebrospinal fluid oxaliplatin contributes to the acute pain induced by systemic administration of oxaliplatin. Anesthesiology. 2016;124(5):1109\u201321. https:\/\/doi.org\/10.1097\/ALN.0000000000001084.","journal-title":"Anesthesiology"},{"issue":"10","key":"2139_CR16","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1158\/1535-7163.MCT-20-0006","volume":"19","author":"XM Wang","year":"2020","unstructured":"Wang XM, Gu P, Saligan L, Iadarola M, Wong SSC, Ti LK, et al. Dysregulation of EAAT2 and VGLUT2 spinal glutamate transports via histone deacetylase 2 (HDAC2) contributes to paclitaxel-induced painful neuropathy. Mol Cancer Ther. 2020;19(10):2196\u2013209. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0006.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2139_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12974-020-01992-1","volume":"17","author":"M Liu","year":"2020","unstructured":"Liu M, Zhang SB, Luo YX, Yang YL, Zhang XZ, Li B, et al. NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel. J Neuroinflamma. 2020;17(1):310. https:\/\/doi.org\/10.1186\/s12974-020-01992-1.","journal-title":"J Neuroinflamma"},{"issue":"7","key":"2139_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00775-011-0823-6","volume":"16","author":"M Namdarghanbari","year":"2011","unstructured":"Namdarghanbari M, Wobig W, Krezoski S, Tabatabai NM, Petering DH. Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem. 2011;16(7):1087\u2013101. https:\/\/doi.org\/10.1007\/s00775-011-0823-6.","journal-title":"J Biol Inorg Chem"},{"key":"2139_CR19","doi-asserted-by":"crossref","unstructured":"Ling XB, Wei HW, Wang J, Kong YQ, Wu YY, Guo JL, et al. Mammalian metallothionein-2A and oxidative stress. Int J Mol Sci. 2016:17(9).","DOI":"10.3390\/ijms17091483"},{"issue":"3","key":"2139_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.pain.2011.11.008","volume":"153","author":"G Oki","year":"2012","unstructured":"Oki G, Wada T, Iba K, Aiki H, Sasaki K, Imai S, et al. Metallothionein deficiency in the injured peripheral nerves of complex regional pain syndrome as revealed by proteomics. Pain. 2012;153(3):532\u20139. https:\/\/doi.org\/10.1016\/j.pain.2011.11.008.","journal-title":"Pain"},{"issue":"18","key":"2139_CR21","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1111\/bph.15142","volume":"177","author":"L Tuure","year":"2020","unstructured":"Tuure L, Pemmari A, Hamalainen M, Moilanen T, Moilanen E. Regulation of gene expression by MF63, a selective inhibitor of microsomal PGE synthase 1 (mPGES1) in human osteoarthritic chondrocytes. Br J Pharmacol. 2020;177(18):4134\u201346. https:\/\/doi.org\/10.1111\/bph.15142.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"2139_CR22","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1523\/JNEUROSCI.23-08-03336.2003","volume":"23","author":"RS Chung","year":"2003","unstructured":"Chung RS, Vickers JC, Chuah MI, West AK. Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury. J Neurosci. 2003;23(8):3336\u201342. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-08-03336.2003.","journal-title":"J Neurosci"},{"issue":"21","key":"2139_CR23","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1007\/s00018-012-1045-y","volume":"69","author":"Y Manso","year":"2012","unstructured":"Manso Y, Carrasco J, Comes G, Adlard PA, Bush AI, Hidalgo J. Characterization of the role of the antioxidant proteins metallothioneins 1 and 2 in an animal model of Alzheimer\u2019s disease. Cell Mol Life Sci. 2012;69(21):3665\u201381. https:\/\/doi.org\/10.1007\/s00018-012-1045-y.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"2139_CR24","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/glia.23465","volume":"66","author":"R Waller","year":"2018","unstructured":"Waller R, Murphy M, Garwood CJ, Jennings L, Heath PR, Chambers A, et al. Metallothionein-I\/II expression associates with the astrocyte DNA damage response and not Alzheimer-type pathology in the aging brain. Glia. 2018;66(11):2316\u201323. https:\/\/doi.org\/10.1002\/glia.23465.","journal-title":"Glia"},{"issue":"24","key":"2139_CR25","doi-asserted-by":"publisher","first-page":"10265","DOI":"10.1158\/0008-5472.CAN-10-2839","volume":"70","author":"S Majumder","year":"2010","unstructured":"Majumder S, Roy S, Kaffenberger T, Wang B, Costinean S, Frankel W, et al. Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes. Cancer Res. 2010;70(24):10265\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2839.","journal-title":"Cancer Res"},{"issue":"1","key":"2139_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1479-5876-11-173","volume":"11","author":"Y Pan","year":"2013","unstructured":"Pan Y, Huang J, Xing R, Yin X, Cui J, Li W, et al. Metallothionein 2A inhibits NF-kappaB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection. J Transl Med. 2013;11(1):173. https:\/\/doi.org\/10.1186\/1479-5876-11-173.","journal-title":"J Transl Med"},{"issue":"1","key":"2139_CR27","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1038\/s41467-019-12049-0","volume":"10","author":"SB Zhang","year":"2019","unstructured":"Zhang SB, Lin SY, Liu M, Liu CC, Ding HH, Sun Y, et al. CircAnks1a in the spinal cord regulates hypersensitivity in a rodent model of neuropathic pain. Nat Commun. 2019;10(1):4119. https:\/\/doi.org\/10.1038\/s41467-019-12049-0.","journal-title":"Nat Commun"},{"issue":"4","key":"2139_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/imcb.12318","volume":"98","author":"X Guo","year":"2020","unstructured":"Guo X, Deng J, Zheng B, Liu H, Zhang Y, Ying Y, et al. HDAC1 and HDAC2 regulate anti-inflammatory effects of anesthetic isoflurane in human monocytes. Immunol Cell Biol. 2020;98(4):318\u201331. https:\/\/doi.org\/10.1111\/imcb.12318.","journal-title":"Immunol Cell Biol"},{"issue":"7749","key":"2139_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/d41586-019-00895-3","volume":"567","author":"A Dance","year":"2019","unstructured":"Dance A. Why the sexes don\u2019t feel pain the same way. Nature. 2019;567(7749):448\u201350. https:\/\/doi.org\/10.1038\/d41586-019-00895-3.","journal-title":"Nature"},{"issue":"43","key":"2139_CR30","doi-asserted-by":"publisher","first-page":"15450","DOI":"10.1523\/JNEUROSCI.3859-11.2011","volume":"31","author":"RE Sorge","year":"2011","unstructured":"Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin JS, Ritchie J, et al. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci. 2011;31(43):15450\u20134. https:\/\/doi.org\/10.1523\/JNEUROSCI.3859-11.2011.","journal-title":"J Neurosci"},{"issue":"8","key":"2139_CR31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nn.4053","volume":"18","author":"RE Sorge","year":"2015","unstructured":"Sorge RE, Mapplebeck JCS, Rosen S, Beggs S, Taves S, Alexander JK, et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nature Neurosci. 2015;18(8):1081\u20133. https:\/\/doi.org\/10.1038\/nn.4053.","journal-title":"Nature Neurosci"},{"issue":"3","key":"2139_CR32","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1158\/1078-0432.CCR-18-1281","volume":"25","author":"S Lin","year":"2019","unstructured":"Lin S, Wang X, Pan Y, Tian R, Lin B, Jiang G, et al. Transcription factor myeloid zinc-finger 1 suppresses human gastric carcinogenesis by interacting with metallothionein 2A. Clin Cancer Res. 2019;25(3):1050\u201362. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1281.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2139_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","volume":"60","author":"K Ren","year":"2009","unstructured":"Ren K, Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res Rev. 2009;60(1):57\u201364. https:\/\/doi.org\/10.1016\/j.brainresrev.2008.12.020.","journal-title":"Brain Res Rev"},{"issue":"5","key":"2139_CR34","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1084\/jem.20170584","volume":"215","author":"K Stockstill","year":"2018","unstructured":"Stockstill K, Doyle TM, Yan X, Chen Z, Janes K, Little JW, et al. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain. J Exp Med. 2018;215(5):1301\u201313. https:\/\/doi.org\/10.1084\/jem.20170584.","journal-title":"J Exp Med"},{"issue":"9","key":"2139_CR35","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/j.1742-4658.2006.05207.x","volume":"273","author":"M Penkowa","year":"2006","unstructured":"Penkowa M. Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J. 2006;273(9):1857\u201370. https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05207.x.","journal-title":"FEBS J"},{"key":"2139_CR36","first-page":"6705424","volume":"2019","author":"M Wu","year":"2019","unstructured":"Wu M, Leng W, Pan H, Lei X, Chen L, Ouyang X, et al. The reduced expression of EOLA1 may be related to refractory diabetic foot ulcer. Mediators Inflamm. 2019;2019:6705424.","journal-title":"Mediators Inflamm"},{"key":"2139_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2017.03.020","volume":"350","author":"H Jakovac","year":"2017","unstructured":"Jakovac H, Grubic Kezele T, Sucurovic S, Mulac-Jericevic B, Radosevic-Stasic B. Osteopontin-metallothionein I\/II interactions in experimental autoimmune encephalomyelitis. Neuroscience. 2017;350:133\u201345. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.03.020.","journal-title":"Neuroscience"},{"issue":"5","key":"2139_CR38","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12031-020-01481-3","volume":"70","author":"J Liu","year":"2020","unstructured":"Liu J, Tan S, Wang Y, Luo J, Long Y, Mei X, et al. Role of metallothionein-1 and metallothionein-2 in the neuroprotective mechanism of sevoflurane preconditioning in mice. J Mol Neurosci. 2020;70(5):713\u201323. https:\/\/doi.org\/10.1007\/s12031-020-01481-3.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"2139_CR39","doi-asserted-by":"publisher","first-page":"14540","DOI":"10.1038\/s41598-017-14860-5","volume":"7","author":"M Pietrucha-Dutczak","year":"2017","unstructured":"Pietrucha-Dutczak M, Smedowski A, Liu X, Matuszek I, Varjosalo M, Lewin-Kowalik J. Candidate proteins from predegenerated nerve exert time-specific protection of retinal ganglion cells in glaucoma. Sci Rep. 2017;7(1):14540. https:\/\/doi.org\/10.1038\/s41598-017-14860-5.","journal-title":"Sci Rep"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02139-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T09:28:49Z","timestamp":1618306129000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02139-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2139"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02139-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-129453\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"12 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Sun Yat-Sen University Animal Care and Use Committee and carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}